A leader in the Canadian seniors’ care and services market
Board of Directors of Extendicare Inc.
Samir Manji
Independent Director, Non-executive Chairman
Mr. Manji is the Executive Chair of RFA Financial Inc. (TSX: RFA) and founder and CEO of Sandpiper Group, a Vancouver-based real estate private equity firm established in 2016. He served as President and CEO, and Trustee, of Artis Real Estate Investment Trust (formerly TSX: AX.UN) from 2021 until its combination with RFA Financial Inc. in February 2026. Mr. Manji has been involved in over $10 billion in hospitality, seniors’ housing and multifamily residential real estate transactions and has over 30 years of experience in real estate and seniors’ housing. Mr. Manji was the founder, Chairman and CEO of Amica Mature Lifestyles Inc. (“Amica”), a TSX-listed company from 1997 until its sale to the Ontario Teachers’ Pension Plan in 2015. Mr. Manji is widely credited with building Amica into a premier high-end independent living brand.
Mr. Manji is a member of the Young Presidents’ Organization and the Chief Executives Organization, and serves as Chair of Focus Humanitarian Assistance Canada. He was recognized in 2006 as a recipient of Canada’s Top 40 Under 40 and was also named the Ernst & Young Entrepreneur of the Year award winner in the business-to-consumer products and services category in British Columbia in 2010.
Mr. Manji graduated from the University of Waterloo and received his CPA, CA with KPMG LLP in Toronto. He was appointed to the Extendicare Board on May 30, 2019, and resides in Vancouver, British Columbia.
Norma Beauchamp (QR)
Independent Director, Chair of the Quality and Risk Committee
Ms. Beauchamp is a corporate director with over 30 years of healthcare experience in corporate and non-profit organizations, including executive positions at Bayer Healthcare (Canada and Global) and Sanofi Canada. Most recently, she served as the President and CEO of Cystic Fibrosis Canada (2014 to 2017). Throughout her career, she has been a patient advocate, working with patient and health care organizations to enhance access to care.
Ms. Beauchamp currently serves on the respective TSX-listed boards of Aurora Cannabis Inc., as Chair of its Nominating and Corporate Governance Committee and a member of its Audit Committee, and HLS Therapeutics Inc., a pharmaceutical company, as Chair of its Compensation and Governance Committee. .
Ms. Beauchamp gives back to her community and serves as a member of the National Research Council of Canada and as a Regional Ambassador and Mentor with Women Get on Board where she connects with women aspiring to serve on boards. In the past, she has served on the respective boards of the Ontario Caregiver Organization, ALS Canada, St. Joseph’s Health Centre Foundation, Providence Healthcare Foundation, Health Charities Coalition of Canada and the Breast Cancer Society of Canada.
Ms. Beauchamp has completed the University of Toronto’s Rotman School of Management Directors Education Program (ICD.D) and holds a Bachelor of Business Administration in Marketing from Bishop’s University. Ms. Beauchamp was appointed to the Board on May 30, 2019, and resides in Toronto, Ontario.
Josh Blair (HRG&S) (I)
Independent Director
Mr. Blair is the Co-Founder and CEO of Impro.AI, a high-tech company that enables corporations and their employees to accelerate their growth through AI-powered workforce insights and performance mentoring. He is also a Partner at Esplanade Ventures, a private venture capital firm focused on the health technology market. He brings over 30 years of experience in executive and board roles within the public and private capital markets across multiple industries, including AI and data services, healthcare and telecommunications. Prior to founding Impro.AI, from 1995 through 2019, Mr. Blair served in increasingly senior leadership roles at TELUS Corporation, including as Group President from 2014 to 2019, overseeing TELUS Digital, TELUS Health, TELUS Business, TELUS Agriculture and TELUS Ventures.
Mr. Blair currently serves on the board of Calian Group Ltd. (TSX: CGY), where he chairs the Human Resources and Compensation Committee and is a member of the Nominating Committee, and as the chair of the board at Straive, a private data analytics and AI company. He previously served on the respective boards of TELUS Digital (NYSE and TSX: TIXT), Neighbourly Pharmacy (TSX: NBLY), Carebook Technologies (TSX: CRBK.V) and the University of Victoria.
Mr. Blair holds a bachelor’s degree in electrical engineering from the University of Victoria and completed the Executive Program at the Smith School of Business at Queen’s University. In 2021, he received an honorary doctorate degree from the University of Victoria in recognition of his career achievements as well as his community contributions. Mr. Blair was appointed to the Board on April 16, 2026, and resides in Vancouver, British Columbia.
Donald E. Clow (A) (I)
Independent Director, Chair of the Investment Committee
Mr. Clow is the President of Rockcliff Ventures Inc., a private real estate investment firm, with deep experience in the real estate sector having held C-suite positions in several organizations. Mr. Clow served as President and CEO of Crombie Real Estate Investment Trust (TSX: CRR.UN) (2009 to 2023), a Canadian real estate investment trust that owns and operates grocery-anchored plazas, grocery stores, retail-related industrial properties and mixed-use residential properties across Canada. Prior to that, Mr. Clow held the position of President of ECL Developments Limited (2007 to 2009), the real estate development subsidiary of Empire Company Limited. He was also President and minority owner of Southwest Properties Limited (1989 to 2005), a private residential and commercial real estate development company in Halifax.
Mr. Clow currently serves as the Independent Lead Trustee of H&R Real Estate Investment Trust (TSX: HR.UN), where he is a member of its Audit Committee, Investment Committee, and Compensation, Environmental, Social, Governance and Nominating Committee, and is a member of the board of Minto Group, a private real estate company, specializing in homebuilding, property management and real estate investment in Canada and the U.S. He is also a member of the board of the Queen Elizabeth II Health Sciences Centre Foundation. Mr. Clow previously served as a Trustee of Granite Real Estate Investment Trust (TSX: GRT.UN) (2016 to 2019).
Mr. Clow was named Waterstone’s Most Admired CEO in Canada (Mid-Market) in 2023, has been inducted into Atlantic Canada’s Top 50 CEOs Hall of Fame, and is a member of the Nova Scotia Sports Hall of Fame as a member of the 1981 Acadia Axemen Football team.
Mr. Clow is an FCPA, FCA, and holds a Bachelor of Business Administration from Acadia University. In addition to leadership programs at the Harvard Business School and the Ivey School of Business, he is a graduate of the Rotman Directors Education Program, is a member of the Young Presidents’ Organization, and a former member of the Chief Executives Organization and the Business Council of Canada. Mr. Clow was appointed to the Board on February 27, 2025, and resides in Halifax, Nova Scotia.
Dr. Michael Guerriere
Non-independent Director, President and Chief Executive Officer
Dr. Guerriere was appointed the President and CEO of Extendicare on October 22, 2018, and has been a member of the Board since March 2018. He has a diverse background with over 35 years of experience in medical practice, hospital operations, management consulting, and health technology. Dr. Guerriere was Chief Strategy Officer of TELUS Health, a provider of technology services to clinical professionals, hospitals, government agencies, health authorities, pharmacies and consumers across Canada, from May 2011 until October 2018. Dr. Guerriere founded Courtyard Group in 2000, an international health care consultancy, where he served as Managing Partner until it was acquired by TELUS Health in 2011. Dr. Guerriere also served 10 years as an executive in university teaching hospitals, including as Executive Vice President and Chief Operating Officer of the University Health Network.
Dr. Guerriere chairs the Health and Life Sciences Advisory Board at the University of Toronto’s Rotman School of Management. He has served on numerous boards, including Toronto Metropolitan University (Chair), MediSolution Ltd. (member of its Audit Committee), Canada Health Infoway (Chair of its Finance Committee), the Canadian Institute for Health Information, and the Institute of Clinical Evaluative Sciences.
Dr. Guerriere has a degree in Medicine and specialty training in Internal Medicine from the University of Toronto, an MBA from the Kellogg School at Northwestern University and an honorary doctorate from Toronto Metropolitan University. Dr. Guerriere was appointed to the Board in March 2018, and resides in Toronto, Ontario.
Sandra L. Hanington (A) (HRG&S)
Independent Director, Chair of the Human Resources, Governance and Sustainablility Committee
Ms. Hanington is a corporate director and advisor, and is a former President and CEO of the Royal Canadian Mint (February 2015 to July 2018). From 1999 until 2011, she held a number of progressively senior executive roles in the financial services sector in North America, culminating as Executive Vice President and a member of the Management Committee of BMO Financial Group. Prior to joining BMO Financial Group, Ms. Hanington worked for Manulife Financial/North American Life Assurance, Royal Trustco Ltd. and Suncor Inc./Sunoco Group.
Ms. Hanington currently serves on the board of the Bank of Canada and as Vice-Chair of the Governing Council of the University of Toronto. Ms. Hanington previously served on the respective boards of The Descartes Systems Group Inc. (TSX: DSG), where she was a member of its Corporate Governance Committee and Compensation Committee, and Aimia Inc. (TSX: AIM), as Chair of its Governance and Human Resources Committee. Ms. Hanington is the co-founder and a director of Jack.org, promoting mental health and wellness for youth in Canada since 2010 and is the recipient of the Meritorious Service Cross from the office of the Governor General for her work with the organization.
Ms. Hanington was named by the Women’s Executive Network (WXN)™ as one of Canada’s Top 100 Most Powerful Women three times in a row, from 2007 to 2009, and was inducted into the WXN Hall of Fame in 2010.
Ms. Hanington holds a BASc from the University of Waterloo, an MBA from the University of Toronto’s Rotman School of Management, and the ICD.D designation from the Institute of Corporate Directors. Ms. Hanington was appointed to the Board in August 2014, and resides in Toronto, Ontario.
Brent Houlden (A) (I)
Independent Director, Chair of the Audit Committee
Mr. Houlden is a corporate director, advisor and interim manager. Most of Mr. Houlden’s career has been spent consulting in the area of strategy and operations, and as a financial advisor on urgent business critical transactions. He is an operator and strategist with a wide breadth of management skills and consulting expertise.
After retiring as a senior Deloitte partner in November 2014, Mr. Houlden has held various management roles including being the CEO of Dealnet Capital (October 2017 to December 2020).
Mr. Houlden currently serves on the respective boards of Corus Orthodontists Inc., Enerkem Inc., and the Mount Pleasant Group of Cemeteries, all private companies. He has previously served on a number of other boards, including that of Dealnet Capital for five years and Deloitte for six years.
Mr. Houlden is a CPA, CA and LIT (retired). He holds an MBA from Queen’s University and the ICD.D designation from the Institute of Corporate Directors. Mr. Houlden was appointed to the Board on May 28, 2020, and resides in Toronto, Ontario.
Heather-Anne Irwin (HRG&S) (QR)
Independent Director
Ms. Irwin is Adjunct Professor of Finance at the University of Toronto’s Rotman School of Management and a corporate director. She is also the Executive Director of the Canadian Securities Institute Research Foundation and the founding President of and advisor to VersaFi (formerly Women in Capital Markets). Ms. Irwin had a 17-year career in capital markets on Bay Street before moving to the Rotman School of Management in 2002, covering equity capital markets, debt capital markets and investment banking at TD Securities (1996 – 2002), Nesbitt Burns (1989 – 1996) and Citibank Canada (1986 – 1989).
Ms. Irwin currently serves on the board of RFA Financial Inc. (TSX: RFA), where she is a member of its Audit Committee and Governance, Nominating and Compensation Committee. She is also a director of the Ontario Financing Authority (a provincial crown corporation), where she sits on its Audit Committee, an advisory member of Sionna Investment Management, and serves on the Independent Review Committee of Starlight Investment Capital. Ms. Irwin previously served on the boards of Artis Real Estate Investment Trust (formerly TSX: AX.UN), where she was a member of its Audit Committee and Governance, Nominating and Compensation Committee; InnVest Real Estate Investment Trust (formerly TSX: INN.UN), where she chaired the Compensation and Corporate Governance Committee; and the Centre for Addiction and Mental Health Foundation.
Ms. Irwin has her ICD.D and teaches in the program. She has an MBA from the Schulich School of Business at York University and Hons B.Sc. Engineering from Queen’s University in Engineering Chemistry. Ms. Irwin was appointed to the Board on February 27, 2025, and resides in Toronto, Ontario.
Leslee Thompson (QR)
Independent Director
Ms. Thompson is a corporate director, independent consultant and health care expert. She most recently served as CEO of Health Standards Organization and Accreditation Canada (2016 – 2026), two global not-for-profit organizations that operate across 45 countries and in every Canadian province and territory. Starting out as an ICU nurse, Ms. Thompson has led multiple organizations across both public and private sectors. She was CEO of Kingston General Hospital (2009 to 2016), and a senior executive at Medtronic Canada, Cancer Care Ontario, Sunnybrook Health Sciences Centre, University Health Network and Capital Health Authority (Edmonton).
Ms. Thompson has been an independent director on the board of Amica since 2015, where she is Chair of the Risk Committee. Her board term will end with the sale of Amica, which is anticipated to close by the end of March 2026. She was on the Board of Shoppers Drug Mart (formerly TSX:SC) for the period of 2002 – 2009 and was a member of the Compensation Committee. She also served on multiple not for profit Boards including International Society for Quality Health Care, Canadian Foundation for Healthcare Improvement (Board Chair) Council for Academic Hospitals of Ontario (Board Chair), Ontario Hospital Association and Ontario Institute for Cancer Research.
Ms. Thompson has been appointed by provincial and federal governments to various panels and advisory councils, and she has published numerous articles on the future of quality and health care. She is also an Executive in Residence at the University of Toronto’s Rotman School of Management. Ms. Thompson’s awards and honours include alumni awards from the University of Toronto and Queen’s University, and she was named one of Canada’s Top 100 Most Powerful Women. Most recently she received the “Legacy of Leadership” award from Canada’s national health care association, HealthCareCAN.
Ms. Thompson holds a Nursing Degree from Queen’s University, Master of Science in Nursing from the University of Toronto, MBA from Western University and the ICD.D designation from the Institute of Corporate Directors. Ms. Thompson was appointed to the Board on April 16, 2026, and resides in Toronto, Ontario.
A: Audit Committee
HRG&S: Human Resources, Governance and Sustainability Committee
I: Investment Committee
QR: Quality and Risk Committee
Honorary Directors of Extendicare
- Dr. Seth B. Goldsmith – Director Emeritus (former board member, 1995 to January 2016)
- Alvin G. Libin – Director Emeritus (former board member, 1984 to January 2016)